Phenylethylmalonamide in essential tremor. A double-blind controlled study.
A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically...
Sparad:
| I publikationen: | J Neurol Neurosurg Psychiatry |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
1981
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC491180/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7031184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.10.932 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|